Top compounds associated with response to LINC00521


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC -0.049 0.2
mRNA CAY10576 CTRPv2 pan-cancer AAC -0.053 0.2
mRNA SR8278 CTRPv2 pan-cancer AAC 0.17 0.2
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.2
mRNA lovastatin CTRPv2 pan-cancer AAC 0.048 0.2
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.044 0.2
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.046 0.2
mRNA nelarabine CTRPv2 pan-cancer AAC -0.05 0.2
mRNA AC55649 CTRPv2 pan-cancer AAC -0.049 0.2
mRNA tandutinib CTRPv2 pan-cancer AAC -0.048 0.2
Download CSV